Information on ARHGEF1

Basic details

Alt. symbols: P115-RHOGEF | SUB1.5 | LBCL2

Approved name: Rho guanine nucleotide exchange factor 1
Alt. names: Rho guanine nucleotide exchange factor (GEF) 1

Location: 19q13.2: 41883173 - 41930150 (+)
Gene type: protein_coding, 27 transcripts.

Scores: LoFtool: 0.217000 | pLI: 0.90949746 | LOEUF: 0.342

HGNC: 681

NCBI: 9138, RefSeq: .0

Ensembl: ENSG00000076928.20

LRG_ | Status: none

OMIM: 601855

Expression | ProteinAtlas

Normal function

ARHGEF1 encodes a protein predominantly expressed in hematopoietic cells and specific for regulation of the GTPase RhoA, which plays a role in cytoskeletal signaling and PI3K/AKT pathway control. ARHGEF1 is involved in the signaling of GPCRs associated with G-alpha 12/13-containing heterotrimeric G proteins AKA guanine nucleotide-binding alpha-12 (GNA12) and alpha-13 (GNA13) subunits (PMID: 9641915, 9641916). It acts as a GTPase-activating protein (GAP) for GNA12 and GNA13, and as guanine nucleotide exchange factor (GEF) for RhoA GTPase (PMID: 30521495, 8810315, 9641915, 9641916), an activity inhibited by binding to activated GNA12 (PMID: 9641916). It has been reported to mediate angiotensin-2-induced RhoA activation (PMID: 20098430).

Dysfunction and disease

Bouafia et al. (2019) reported compound heterozygous ARHGEF1 mutations (c.898 C>T; p.R300*/c.1669-1G>T) in 2 siblings with low IgG levels and impaired vaccine responses, as well as clinical features of recurrent viral and severe sinopulmonary infections and bronchiectasis (PMID: 30521495). One of the sisters also showed low IgM levels, autoimmune cytopenia, and low isohemagglutinin titers. Both had low absolute B cell counts, as well as reduced MZ, memory and switched memory B cell proportions w ith relatively increased transitional B cells, T cell subset abnormalities and circulating immature myeloid cells (a feature not observed in ARHGEF1 LOF mouse models). Patient T and B cells showed low RhoA activity and low cortical F-actin polymerization, leading to impaired regulation of AKT/mTOR signaling and impaired lymphocyte migration with consequently disrupted B cell distribution within GCs. [Load More]

[Reviewed by Xiao P. Peng on 2024-07-29 00:59:43]

Associated conditions

Acronym Condition's_name MOI Mode_of_actionwww icon OMIM_ID No.cases
CVID18 Immunodeficiency, common variable, 18 ARdict. icon Loss of Function 618459www icon 0 (0 fams)

Please mind that full curation (inclusion of all published patients) of this gene has not started yet. Please contact us if you want to volunteer.

Transcripts of ARHGEF1

Name ENSEMBL_ID LRG_ID CCDS_ID MANE Transcript.type Exons Canonical CDS_length REFSEQ_ID
203 ENST00000354532.8 CCDS12591 Select protein_coding 29 Yes 3229 NM_001396006,NM_004706
204 ENST00000378152.8 protein_coding 27 No 2986 NM_001396004
201 ENST00000337665.8 CCDS12590 protein_coding 29 No 3171 NM_199002
202 ENST00000347545.8 CCDS12592 protein_coding 28 No 3091 NM_198977
219 ENST00000599846.6 protein_coding 30 No 3393 NM_001396000
227 ENST00000706938.1 protein_coding No XM_047439663
224 ENST00000698932.1 protein_coding No NM_001396002,NM_001396003

Published variants

Found 2 variants

Var.name Exon/Intron cDNA_pos. CDS_change Prot.change Var.type Var.class. Patients
upstream_gene_variant Pathogenic 0
upstream_gene_variant Pathogenic 0

Please mind that full curation (inclusion of all published variants) of this gene has not started yet. Please contact us if you want to volunteer.

Diagnostic pitfalls & paradigms

Considerations to take into account when analyzing this gene

Year Paradigm ⓘ PMID Notes
- Regions of Homology -
-Cryptic splicing-Unreported or not recorded in our DB.
-Uniparental disomy-Unreported or not recorded in our DB.
-Mosaicism-Unreported or not recorded in our DB.
-Incomplete penetrance-Unreported or not recorded in our DB.
-Di-/oligo-genic inheritance-Unreported or not recorded in our DB.
-Somatic reversion-Unreported or not recorded in our DB.

References linked to variants in ARHGEF1

ID Year Title Journal PMID Variants
81 2009 Primary B cell immunodeficiencies: comparisons and contrasts... Annu. Rev. Immunol 19302039 2
84 2002 Novel Igalpha (CD79a) gene mutation in a Turkish patient wit... Am. J. Med. Genet. 11920841 1
85 2018 IgM Augments Complement Bactericidal Activity with Serum fro... JoCI 29335801 2
86 2014 Autosomal recessive agammaglobulinemia: a novel non-sense mu... JoCI 24481606 1
87 1999 Mutations in Igalpha (CD79a) result in a complete block in B... J. Clin. Investig. 10525050 1

Phenotypic & functional assays available?

Find laboratories offering tests

Check